All In MedTech

Device Trial Radar · NCT03936244

Bipolar Plasmakinetic TURP Vs Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms

Randomized Controlled Trial Comparing Bipolar Plasmakinetic Transurethral Resection of the Prostate With Monopolar Transurethral Resection of the Prostate in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Last checked: Nov 19, 2026Latest source record: Nov 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

Dec 5, 2014

Primary completion

Dec 12, 2017

Study completion Dec 12, 2019

Sponsor

Lead sponsor
Hospital Universitario de FuenlabradaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 3, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomized controlled trial with one-year follow-up comparing intra, peri and postoperative outcomes for plasmakinetic transurethral resection of prostate (PK-TURP) and monopolar transurethral resection of prostate (M-TURP) in the treatment of LUTS due to BPH in a tertiary-care public institution

Conditions

  • Prostatic Hyperplasia
  • Lower Urinary Tract Symptoms
  • Transurethral Resection of Prostate

Interventions

  • Transurethral Resection of the Prostate (TURP)Device

    Randomized allocation to M-TURP or PK-TURP

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. International Prostate Symptom Score (IPSS)Time frame: 12 months
  2. Maximum Urinary Flow Rate (QmaxTime frame: 12 months
  3. Postvoid Residual Urine (PVRU) VolumeTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital Universitario de Fuenlabrada

    Fuenlabrada, Madrid, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.